The most prevalent infection in the world is dermatophytosis, which is a major issue with
high recurrence and can affect the entire body including the skin, hair, and nails. The major …

Fungal diseases have posed a great challenge to global health, but have fewer solutions
compared to bacterial and viral infections. Development and application of new treatment …

The high occurrence of mycological resistance to conventional antifungal agents results in
significant illness and death rates among immunodeficient patients. In addition, the …

The newly emerged pathogen, Candida auris, presents a serious threat to public health
worldwide. This multidrug-resistant yeast often colonizes and persists on the skin of patients …

Candida auris (C. auris), an emerging multidrug-resistant microorganism, with limited
therapeutical options, is one of the leading causes of nosocomial infections. The current …

Carbon nanotubes (CNTs) have emerged as the brightest nascent artifact to deliver
antifungal drugs in drug delivery applications, health care, and pharmaceutical industries …

Five silver (I) complexes, namely chloro [1-methallyl-3-benzyl) benzimidazol-2-ylidene]
silver (6), chloro [1-methallyl-3-(2, 3, 5, 6-tetramethylbenzyl) benzimidazol-2-ylidene] silver …

An exclusive site for local drug delivery is the vagina, especially for vaginal infections. The
fungus Candida albicans causes vaginal infection known as vulvovaginal candidiasis, a …

Multidrug resistance Candida auris is a dangerous fungal pathogen that is emerging at an
alarming rate and posing serious threats to public health. C. auris is associated with …

Given the risks associated with synthetic fungicides, it is crucial to explore safe and
sustainable alternatives. One potential solution is using bioactive natural products (BNPs) …